1. Medtech Insight
  2. >>Business
  3. >>R&D
  4. >>Clinical Trials

Cardio Catch-Up: Two Studies Support Boston Scientific’s Subcutaneous ICD

 
• By Reed Miller

Medtech Insight’s Cardiovascular Catch-Up highlights recent news on cardiovascular tech innovations that you may have missed. This edition covers the two clinical studies of Boston Scientific's Emblem MRI subcutaneous implantable cardioverter defibrillator.

Emlem S-ICD
Boston Scientific's Emblem S-ICD • Source: Boston Scientific

A secondary analysis of the 450-patient, randomized ATLAS trial suggests Boston Scientific's Emblem MRI subcutaneous implantable cardioverter defibrillator (S-ICD) can help prevent tricuspid valve regurgitation in arrhythmia patients.

Darryl Leong from McMaster University in Hamilton, Ontario presented the research at the Heart Rhythm 2023 conference in New...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D

Johnson & Johnson MedTech: How To Scale Digital Solutions

 
• By Natasha Barrow

J&J's EMEA head of digital solutions, Julia Fishman, talks about the major hurdles in scaling digital innovation, tips for clinical adoption and what’s up next on J&J’s innovation road map. Robot-assisted surgery pioneer Ivo Broeders gives his perspective on the difficulties in clinical adoption.

J&J MedTech Launches KINCISE 2 Surgical Automated System In US

 
• By Natasha Barrow

The KINCISE 2 Surgical Automated System aims to “reduce the physical burden on surgeons compared to manual impaction in primary and revision hip and revision knee replacement procedures,” said J&J MedTech.

Abbott Launches Next-Gen Delivery System For Proclaim DRG Neurostim

 
• By Shubham Singh

Allen Burton, Abbott’s medical director of neuromodulation told Medtech Insight that the delivery system was developed to make the procedure easier for physicians, especially those who perform the implantations infrequently.